Devin Otto

Devin Otto is a scientist with extensive experience in the biotechnology sector, currently working at Allogene Therapeutics since February 2021, focusing on developing universal CAR-T cancer therapies and constructing MLOps pipelines for data analysis. Previously, Devin held positions at Juno Therapeutics, where skills in patient process operations for CAR-T therapies were honed, and at Kite Pharma, contributing to the commercial manufacturing of Yescarta®. Earlier roles include participating in research at UC Davis, performing laboratory analysis during an internship at Celprogen, and managing technology support and improvements in various capacities. Devin Otto holds a Bachelor's degree in Plant Molecular Biology from the University of California, Davis.